Ronald Merriman, Director at HAEMONETICS CORP (HAE), sold 13,602 shares at $35.89 ($486K) on 2014-08-12, disclosed to the SEC on 2014-08-14.
Seasonal sale ($486k) by Director — this insider has traded HAE in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.73 | 11,328 | $405K | 83.2% |
| 2 | $35.89 | 2,274 | $82K | 16.8% |
| Total | $35.76 avg | 13,602 | $486K | 100% |
| Filing → |
| O | SELL | 2021-06-15 | $280K | — | Filing → |
| NVT | SELL | 2020-11-05 | $80K | — | Filing → |
| AYR | SELL | 2019-05-29 | $201K | — | Filing → |